Published in Gynecol Oncol on September 01, 1989
Expression of c-myc and c-fms oncogenes in trophoblastic cells in hydatidiform mole and normal human placenta. J Clin Pathol (1993) 0.83
Clinicopathologic profile of gestational trophoblastic disease. Wien Klin Wochenschr (2003) 0.80
Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med (1999) 5.89
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol (2001) 4.97
Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol (1997) 3.76
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.06
Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol (1993) 2.42
A prospective controlled trial of early postoperative oral intake following major abdominal gynecologic surgery. Gynecol Oncol (1997) 2.23
Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol (1987) 2.12
Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival. Ann Oncol (2003) 2.08
Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology (1991) 1.86
The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases. Cancer (1984) 1.85
Redefining the target: chemotherapeutics as antiangiogenics. J Clin Oncol (2001) 1.84
The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era. Ann Oncol (2003) 1.83
Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. J Natl Cancer Inst (2001) 1.65
Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res (2001) 1.64
Primitive neuroectodermal tumors arising in testicular germ cell neoplasms. Am J Surg Pathol (1997) 1.64
Secondary ovarian neoplasia. A clinicopathologic study of 35 cases. Cancer (1984) 1.61
Malignant rhabdoid tumor of the vulva: is distinction from epithelioid sarcoma possible? A pathologic and immunohistochemical study. Am J Surg Pathol (1989) 1.61
Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide. Oncogene (2000) 1.57
Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol (1985) 1.56
Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. Cancer Res (1986) 1.53
Astrocytic tumors of the retina. Differentiation of sporadic tumors from phakomatosis-associated tumors. Arch Pathol Lab Med (1984) 1.49
A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol (1989) 1.47
The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol (1995) 1.47
Intravenous leiomyomatosis of the uterus with extension into the heart. Am J Med (1980) 1.45
Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. Gastrointest Endosc (1999) 1.45
Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol (1985) 1.44
Colonic adenomas in asymptomatic women with a history of breast cancer. Am J Gastroenterol (1993) 1.44
A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. J Clin Oncol (1985) 1.43
Evidence for the transformation of seminoma to yolk sac tumor, with histogenetic considerations. Am J Clin Pathol (1992) 1.42
Mucinous cystadenocarcinoma of the retroperitoneum. Obstet Gynecol (1977) 1.31
The pathology of late recurrence of testicular germ cell tumors. Am J Surg Pathol (2000) 1.30
Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. J Clin Oncol (1993) 1.29
Desmoplastic small round cell tumors of the paratesticular region. A report of six cases. Am J Surg Pathol (1997) 1.29
Mitoxantrone for carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group. Cancer Treat Rep (1987) 1.28
A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study. Cancer (1986) 1.25
Taxanes in the treatment of breast cancer: a prodigy comes of age. Cancer Invest (1999) 1.19
Renal cell carcinoma metastatic to the testis and its adnexa: a report of five cases including three that accounted for the initial clinical presentation. Int J Surg Pathol (2001) 1.18
Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am J Obstet Gynecol (1988) 1.16
Abdominal sacral colpopexy with Mersilene mesh in the retroperitoneal position in the management of posthysterectomy vaginal vault prolapse and enterocele. Am J Obstet Gynecol (1985) 1.16
Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells. J Lab Clin Med (1997) 1.15
Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation. Cell Immunol (1994) 1.15
Effects of doxycycline on in vitro growth, migration, and gelatinase activity of breast carcinoma cells. J Lab Clin Med (1995) 1.14
The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection. J Urol (1994) 1.12
Necrotizing fasciitis of vulvar origin in diabetic patients. Obstet Gynecol (1984) 1.10
Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group. Am J Clin Oncol (1984) 1.10
Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer. Biochem Biophys Res Commun (2000) 1.10
Spindle cell mural nodules in cystic ovarian mucinous tumors. A clinicopathologic and immunohistochemical study of five cases. Am J Surg Pathol (1991) 1.09
Gynecologic cancers metastatic to the breast. J Am Coll Surg (1998) 1.08
A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood (1996) 1.07
Twin study: relationship between birth weight, zygosity, placentation, and pathologic placental changes. Acta Genet Med Gemellol (Roma) (1988) 1.06
Large cell calcifying Sertoli cell tumor of the testis: contrasting features of six malignant and six benign tumors and a review of the literature. Am J Surg Pathol (1997) 1.05
Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary. Obstet Gynecol (1994) 1.05
Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Arch Pathol Lab Med (2001) 1.05
Poorly differentiated (small cell) carcinoma of the ovary in young women: evidence supporting a germ cell origin. Hum Pathol (1987) 1.03
Utilization of exogenous fatty acids for complex lipid biosynthesis and its effect on de novo fatty acid formation in Escherichia coli K-12. Biochemistry (1973) 1.02
Angiosarcoma associated with germ cell tumors. Hum Pathol (1985) 1.01
The role of chemotherapy for metastatic breast cancer. Hematol Oncol Clin North Am (1999) 1.01
Monoclonal antibody storage conditions, and concentration effects on immunohistochemical specificity. J Histochem Cytochem (1983) 1.01
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment. J Clin Oncol (1998) 1.01
Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications. Am J Obstet Gynecol (1981) 1.01
The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol (2000) 1.00
Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors. J Urol (1996) 0.99
Effects of doxycycline on human prostate cancer cells in vitro. Cancer Lett (1998) 0.98
Intramural papilloma of the vagina: evidence of Müllerian histogenesis. Cancer (1981) 0.97
Experimental basis of cord blood transplantation. Bone Marrow Transplant (2009) 0.97
Molecular genetic evidence for different clonal origin of components of human renal angiomyolipomas. Am J Surg Pathol (2001) 0.97
Human papillomavirus deoxyribonucleic acid in lesions of the female genital tract: evidence for type 6/11 in squamous carcinoma of the vulva. Obstet Gynecol (1987) 0.96
Adult primary pure teratoma of the testis. The Indiana experience. Cancer (1995) 0.95
Solitary necrotizing granulomas of the lung: differentiating features and etiology. Am J Surg Pathol (1980) 0.95
Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor. Ann Oncol (2010) 0.95
Unusual neoplasms detected in testis cancer patients undergoing post-chemotherapy retroperitoneal lymphadenectomy. J Urol (1994) 0.94
Relationship between platinum-DNA adducts in leukocytes of patients with advanced germ cell cancer and survival. Clin Cancer Res (1996) 0.94
MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer (2004) 0.93
Hormonal treatment of an endometrial stromal nodule followed by local excision. Obstet Gynecol (1999) 0.93
Progestin- and androgen-binding components in a human granulosa-theca cell tumor. Gynecol Oncol (1982) 0.92
Evaluation of the reproducibility of the World Health Organization classification of common ovarian cancers. With emphasis on methodology. Arch Pathol Lab Med (1987) 0.92
Group B streptococcal necrotizing fasciitis arising from an episiotomy. Obstet Gynecol (1985) 0.92
Unusual neoplasms detected in testicular cancer patients undergoing postchemotherapy retroperitoneal lymphadenectomy. World J Urol (1994) 0.92
Spermatocytic seminoma: an immunohistochemical study. Hum Pathol (1994) 0.92
Miscellaneous rare paratesticular tumors. Semin Diagn Pathol (2000) 0.91
Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma. J Clin Oncol (1989) 0.91
Juxtaglomerular cell tumor of the kidney. Cancer (1984) 0.91
Pathology residents' use of a Web-based tutorial to improve Gleason grading of prostate carcinoma on needle biopsies. Hum Pathol (2000) 0.91
A buckling region in locust hindlegs contains resilin and absorbs energy when jumping or kicking goes wrong. J Exp Biol (2012) 0.91
Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial. J Clin Oncol (2004) 0.90
An evaluation of the usefulness of amylase isozyme differentiation in patients with hyperamylasemia. Am J Clin Pathol (1976) 0.90
Life-threatening hemorrhage complicating sacral colpopexy. Am J Obstet Gynecol (1981) 0.90
Distal colonic hyperplastic polyps do not predict proximal adenomas in asymptomatic average-risk subjects. Gastroenterology (1992) 0.90